Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

The Megsin-Cre transgene is a new tool for genetic manipulation in the skin and upper digestive tract.

Different miRNAs in Rex rabbit skin affect cell processes and hair growth.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Dicer is crucial for hair growth in mice.

Mrp3 may aid in wound healing and hair growth.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

A new peptide, murikal/SPR4, was found to significantly increase hair growth in mice, and its liposomal topical formulations enhanced hair growth more than commercial products. However, results on human scalp skin were unclear, needing more tests.

FP-1 is a key protein in rat hair growth, active only during the growth phase.

The treatments stopped hair regrowth in mice.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Overexpressing NSD3 in mice causes breast cancer-like tumors and gland abnormalities.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

Researchers created specific antibodies that detect a protein important in development and various conditions, and can be used for research and diagnosis.

Meis1 is crucial for skin health and tumor development.

Researchers found a new gene variant linked to a rare bone disease, which doesn't always cause symptoms in carriers.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

Deleting the MAD2L1 gene is tolerated in certain mouse cancer models.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

A specific RNA can help hair growth in baldness by boosting stem cell activity.